China Medical System Holdings Ltd (867):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】China Medical System Holdings Ltd (867) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C7985)・商品コード:DATA904C7985
・発行会社(調査会社):GlobalData
・発行日:2018年10月
・ページ数:33
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥55,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥83,250見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
China Medical System Holdings Ltd (CMS) is a pharmaceutical service provider that markets, promotes, and sells prescription drugs to all therapeutic departments in hospitals. The company offers products such as deanxit, ursofalk, augentropfen stulln mono eye-drops, exacin, xinhuosu, salofalk, bioflor, ganfule, and cystistat. It also offers shaduolika, yinuoshu, xidakang and astragalus. CMS partners include AstraZenca, H.Lundbeck A/S, Dr.Falk Pharma Gmbh, Bicodex, Pharma Stulln Gmbh, DKSH. Nordmark Arzneimittel GmbH & Co. KG. It has pharmaceutical manufacturing sites in Shenzhen, Hunan and Hebei Province. The company serves physicians, patients and specialty pharmaceutical companies. CMS is headquartered in Shenzhen, China.

China Medical System Holdings Ltd (867) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
China Medical System Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
China Medical System Acquires Six Products from Venus Pharma 12
China Medical System Acquires Rights to Imdur from AstraZeneca 13
China Medical System to Acquire Combizym and Hirudoid from Dksh for USD79.6 Million 14
China Medical System Acquires Rights to Lamisil and Parlodel from Novartis 15
China Medical System Acquires Product Rights from Pharma Stulln for USD13.6 Million 17
China Medical System Acquires Rights to XiDaKang from Kangzhe Guangming 18
Venture Financing 19
Acticor Biotech Raises USD17.7 Million in Series B Financing 19
Partnerships 21
Destiny Pharma Enters into Agreement with China Medical System 21
Licensing Agreements 22
CMS Medical Enters into Licensing Agreement with Can-Fite BioPharma 22
China Medical System Enters into Licensing Agreement with AstraZeneca 23
China Medical System Enters into Licensing Agreement with Faron Pharma 24
China Medical System Enters Into Licensing Agreement With Biocodex For Stimol 25
Equity Offering 26
Destiny Pharma Raises USD2.4 Million in Private Placement of Shares 26
Acquisition 27
China Medical System Acquires 52% Stake in Hebei Xili Xinglong Pharma 27
China Medical System Holdings Ltd – Key Competitors 28
China Medical System Holdings Ltd – Key Employees 29
China Medical System Holdings Ltd – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Corporate Communications 31
Oct 18, 2017: China Medical System Holdings: Further Announcment in Relation to Resignation of Ms. Sa Manlin as Executive Director 31
Oct 17, 2017: China Medical System Holdings: Resignation of Executive Director 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Medical System Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
China Medical System Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
China Medical System Acquires Six Products from Venus Pharma 12
China Medical System Acquires Rights to Imdur from AstraZeneca 13
China Medical System to Acquire Combizym and Hirudoid from Dksh for USD79.6 Million 14
China Medical System Acquires Rights to Lamisil and Parlodel from Novartis 15
China Medical System Acquires Product Rights from Pharma Stulln for USD13.6 Million 17
China Medical System Acquires Rights to XiDaKang from Kangzhe Guangming 18
Acticor Biotech Raises USD17.7 Million in Series B Financing 19
Destiny Pharma Enters into Agreement with China Medical System 21
CMS Medical Enters into Licensing Agreement with Can-Fite BioPharma 22
China Medical System Enters into Licensing Agreement with AstraZeneca 23
China Medical System Enters into Licensing Agreement with Faron Pharma 24
China Medical System Enters Into Licensing Agreement With Biocodex For Stimol 25
Destiny Pharma Raises USD2.4 Million in Private Placement of Shares 26
China Medical System Acquires 52% Stake in Hebei Xili Xinglong Pharma 27
China Medical System Holdings Ltd, Key Competitors 28
China Medical System Holdings Ltd, Key Employees 29
China Medical System Holdings Ltd, Other Locations 30

List of Figures
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
China Medical System Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
China Medical System Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★調査レポート[China Medical System Holdings Ltd (867):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C7985)販売に関する免責事項を必ずご確認ください。
★調査レポート[China Medical System Holdings Ltd (867):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆